Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tiny, magnetic spheres may help overcome gene therapy hurdle

19.09.2002


The average person’s heart pumps about a gallon of blood per minute, a rate that can easily triple or quadruple during exercise.



The rapid flow of blood through the body is a major roadblock to the use of gene therapy to cure diseases. When injected into the blood, vector viruses – which carry corrective genes – tend to shoot past the target organ or tissue rather than sticking to it, like grains of sand moving past stones in a fast-flowing river.

Now, University of Florida gene therapy and biomedical engineering researchers have demonstrated a novel approach to the problem. In a July article in Molecular Therapy, they report attaching the adeno-associated virus, a widely used gene carrier, to the surface of tiny manufactured balls known as microspheres, each containing a miniscule particle of iron oxide. Using a magnet placed under culture dishes, the researchers were able to coax large amounts of the microspheres to target areas of the cultures. In related experiments in mice, the researchers showed the microspheres clung to cells or organs longer than the virus alone did.


The procedure, reminiscent of the toy that moves magnetized objects beneath transparent plastic, could someday evolve into a treatment that would enable doctors to guide corrective gene-containing microspheres injected into a patient with magnets placed outside the skin. Such procedures, could, for example, replace invasive catheterizations used to treat lung and heart diseases, the researchers said.

"By packaging the virus with the microsphere, we both guided it to the targeted area and got it to stick there," said Barry Byrne, the lead researcher and a pediatric cardiologist with the UF College of Medicine who is affiliated with the UF Genetics Institute.

Byrne and Cathryn Mah, an assistant research professor in the department of pediatrics, collaborated on the project with UF colleagues in pharmaceutics, genetics, and materials science and engineering. The effort, partially funded by the Whitaker Foundation, is part of UF’s growing biomedical engineering initiative involving a wide range of medical and engineering researchers.

Byrne said the adeno-associated virus, a virus that is an ideal gene carrier because it is not associated with any disease, is expensive and time consuming to manufacture in quantity. As a result, if it is ever to be widely used in treating disease, clinicians must have the ability to bind it specifically to the organ, tissue or cells they hope to treat, instead of having it dispersed through the body thus diminishing its effect.

"There is no way you could provide a systemic therapy spread throughout the body if you were only after the kidney, for example," said Byrne, of UF’s Powell Gene Therapy Center. "That even applies to dosing a mouse. Gene therapies are actually unachievable without some type of targeting."

It also is important to avoid unintentional release of therapeutic genes into reproductive cells in part so that engineered genes are not passed on to children, effectively altering the human genome, Byrne said. Proof that therapeutic genes do not spread beyond their targets – such dispersion could cause tumors in non-targeted cells – is one of the Food and Drug Administration’s main criteria for approving gene therapies, he said.

Mah said the UF team’s experiments were conducted over a period of about two years, much of that time devoted to the experiments in mice. In one experiment, the team injected the virus-coated microspheres into the tail veins of three mice and the free virus into the tail veins of three others. They monitored what happened by tracking "marker" proteins produced by the virus. The procedure was similar with cell cultures containing either the free virus or the virus-coated microspheres, with the researchers tracking the marker proteins through a technique called fluorescence microscopy, in which the proteins appear fluorescent green.

The results were impressive. The mice tail vein experiments revealed 10 times the expression of the marker protein in the target organ – the lung – than in other organs, indicating the microspheres both could be targeted and made to reside longer in their target than the free virus. In the cell cultures, meanwhile, the researchers achieved more than 100 times the expression of the marker protein in the magnetized areas of the culture versus the others.

"If you think about it in terms of making doses, it might take about six months to make a single-patient dose of this vector currently," Byrne said. "If this works, I’d say we could do it in four to six weeks or even less."

The microspheres used in the experiment were polystyrene, a type of plastic. In order for the spheres to be used in actual treatment, they would have to be made of biodegradable materials, said Chris Batich, a UF professor of materials science and engineering and biomedical engineering and member of the team. Although he said he has created such biodegradable microspheres since the project was first launched, they have yet to be tested. Among other challenges, researchers will have to prove the microspheres are harmless, efficient and predictable before they can be considered for use in clinical treatment, he said.

"You have to make sure they have the right properties," he said. "They have to have enough iron oxide to be pulled by the magnetic field, and you have to make sure they have the right rate of degradation, whether its two hours or two weeks."


Writer: Aaron Hoover, ahoover@ufl.edu
Sources: Barry Byrne, (352) 846-1531, bbyrne@ufl.edu
Chris Batich, (352) 392-6630,cbati@ufl.edu

Barry Byrne | EurekAlert!
Further information:
http://www.ufl.edu/

More articles from Health and Medicine:

nachricht Finding new clues to brain cancer treatment
21.02.2020 | Case Western Reserve University

nachricht UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Active droplets

21.02.2020 | Medical Engineering

Finding new clues to brain cancer treatment

21.02.2020 | Health and Medicine

Beyond the brim, Sombrero Galaxy's halo suggests turbulent past

21.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>